Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RABGAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KCTD16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEA10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DRAXIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MOGAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WHSC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFATC2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF5C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGBL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XCR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAT8L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NALCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on